1.97 Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says

News


<< back

Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says
Date: 2024-04-12 [news.yahoo.com]

READ THE FULL NEWS >>
×